The second step, is to write a speech outline. Hear how Darren suggests you write your speech outline.
Since the first therapeutic application of a r-protein produced in mammalian cells was approved in 1986. (human tissue plasminogen activator, tPA, Genentech), biopharmaceuticals have changed the. landscape for the treatment of many diseases, including many types of cancer, rheumatic conditions. and orphan diseases.
Production and current applications. Worldwide production of R-22 in 2008 was about 800 Gg per year, up from about 450 Gg per year in 1998, with most production in developing countries. R-22 use is increasing in developing countries, largely for air conditioning applications. Air conditioning sales are growing 20% annually in India and China.